BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10415518)

  • 21. The role of mitochondrial K(ATP) channels in antiarrhythmic effects of ischaemic preconditioning in dogs.
    Végh A; Parratt JR
    Br J Pharmacol; 2002 Dec; 137(7):1107-15. PubMed ID: 12429584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration.
    Lim KH; Javadov SA; Das M; Clarke SJ; Suleiman MS; Halestrap AP
    J Physiol; 2002 Dec; 545(3):961-74. PubMed ID: 12482899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial K(ATP) channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation.
    Carroll R; Gant VA; Yellon DM
    Cardiovasc Res; 2001 Sep; 51(4):691-700. PubMed ID: 11530102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide.
    Wang Y; Kudo M; Xu M; Ayub A; Ashraf M
    J Mol Cell Cardiol; 2001 Nov; 33(11):2037-46. PubMed ID: 11708847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium-activated potassium channel triggers cardioprotection of ischemic preconditioning.
    Cao CM; Xia Q; Gao Q; Chen M; Wong TM
    J Pharmacol Exp Ther; 2005 Feb; 312(2):644-50. PubMed ID: 15345753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial Ca2+-activated K+ channels in cardiac myocytes: a mechanism of the cardioprotective effect and modulation by protein kinase A.
    Sato T; Saito T; Saegusa N; Nakaya H
    Circulation; 2005 Jan; 111(2):198-203. PubMed ID: 15623543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation.
    Brennan JP; Southworth R; Medina RA; Davidson SM; Duchen MR; Shattock MJ
    Cardiovasc Res; 2006 Nov; 72(2):313-21. PubMed ID: 16950237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance.
    Katakam PV; Jordan JE; Snipes JA; Tulbert CD; Miller AW; Busija DW
    Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R920-6. PubMed ID: 17008456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated pharmacological preconditioning in combination with adenosine, a mitochondrial KATP channel opener and a nitric oxide donor.
    Uchiyama Y; Otani H; Okada T; Uchiyama T; Ninomiya H; Kido M; Imamura H; Nakao S; Shingu K
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):148-59. PubMed ID: 12878950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning.
    Korge P; Honda HM; Weiss JN
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3312-7. PubMed ID: 11867760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
    Hausenloy DJ; Maddock HL; Baxter GF; Yellon DM
    Cardiovasc Res; 2002 Aug; 55(3):534-43. PubMed ID: 12160950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning.
    Sasaki N; Murata M; Guo Y; Jo SH; Ohler A; Akao M; O'Rourke B; Xiao RP; Bolli R; Marbán E
    Circulation; 2003 Mar; 107(8):1183-8. PubMed ID: 12615799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preconditioning with diazoxide prevents reoxygenation-induced rigor-type hypercontracture.
    Abdallah Y; Wolf C; Meuter K; Piper HM; Reusch HP; Ladilov Y
    J Mol Cell Cardiol; 2010 Jan; 48(1):270-6. PubMed ID: 19406125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of mitochondrial permeability transition pore and mitochondrial ATP-sensitive potassium channels in the protective effects of ischemic preconditioning in isolated hearts from fed and fasted rats.
    Prendes MG; Hermann R; Torresin ME; Vélez D; Savino EA; Varela A
    J Physiol Biochem; 2014 Sep; 70(3):791-800. PubMed ID: 25034332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial potassium ATP channels and retinal ischemic preconditioning.
    Roth S; Dreixler JC; Shaikh AR; Lee KH; Bindokas V
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2114-24. PubMed ID: 16639023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide.
    Mocanu MM; Maddock HL; Baxter GF; Lawrence CL; Standen NB; Yellon DM
    Circulation; 2001 Jun; 103(25):3111-6. PubMed ID: 11425777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early opening of sarcolemmal ATP-sensitive potassium channels is not a key step in PKC-mediated cardioprotection.
    Brennan S; Jackson R; Patel M; Sims MW; Hudman D; Norman RI; Lodwick D; Rainbow RD
    J Mol Cell Cardiol; 2015 Feb; 79():42-53. PubMed ID: 25450614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.
    Garlid KD; Paucek P; Yarov-Yarovoy V; Murray HN; Darbenzio RB; D'Alonzo AJ; Lodge NJ; Smith MA; Grover GJ
    Circ Res; 1997 Dec; 81(6):1072-82. PubMed ID: 9400389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual roles of mitochondrial K(ATP) channels in diazoxide-mediated protection in isolated rabbit hearts.
    Wang S; Cone J; Liu Y
    Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H246-55. PubMed ID: 11123239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of mitochondrial ATP-sensitive potassium channels delays ischemia-induced cellular uncoupling in rat heart.
    Shen YL; Chen YY; Wu XD; Bruce IC; Xia Q
    Acta Pharmacol Sin; 2004 Jan; 25(1):22-8. PubMed ID: 14704118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.